This inventor holds 1 USPTO granted patent. Top assignee: Philogen S.p.a.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Simon Brack - Innovator in Cancer Treatment
Introduction
Simon Brack is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of medical research, particularly in the development of innovative therapies for cancer treatment. His work focuses on specific binding members against the extracellular matrix protein tenascin-C.
Latest Patents
Simon Brack holds a patent for "Antibodies against Tenascin-C." This patent includes specific binding members against tenascin-C, especially scFv antibody molecules targeting domain A1, domain C, and domain D of tenascin-C. The patent also covers anti-tenascin-C specific binding members conjugated with labels, cytotoxic molecules, or cytokines. These innovations are crucial for the diagnosis and treatment of cancer.
Career Highlights
Brack's career is marked by his dedication to advancing cancer therapies. His work at Philogen S.p.a. has positioned him as a key player in the biotechnology sector. His research has the potential to improve patient outcomes through targeted therapies.
Collaborations
Simon collaborates with talented individuals such as Michela Silacci and Dario Neri. These partnerships enhance the research and development of innovative cancer treatments.
Conclusion
Simon Brack's contributions to the field of cancer treatment through his patented innovations demonstrate his commitment to improving healthcare. His work continues to inspire advancements in medical research and therapy development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile